Onco-Innovations Limited
ONCO
| 01/31/2026 | 10/31/2025 | 07/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -34.05% | -1,862.67% | -734.10% | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 100.69% | 135,469.23% | -39.74% | ||
| Change in Net Operating Assets | 221.57% | -643.56% | -- | ||
| Cash from Operations | 73.32% | -572.54% | -1,109.58% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -- | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -99.99% | 837.41% | 2,144.24% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 100.00% | -- | -- | ||
| Cash from Financing | -99.98% | 764.02% | 2,135.85% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -160.45% | 444.41% | -1,851.43% | ||